# RIMEGEPANT
> **ANDA219399** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX CORP · Approved 2025-12-31
## Drug
- **FDA Application Number:** ANDA219399
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIMEGEPANT
- **Generic name:** Rimegepant
- **Active ingredients:** RIMEGEPANT
- **Dosage form:** TABLET, ORALLY DISINTEGRATING
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** APOTEX CORP
- **First approval:** 2025-12-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219399)
---
*MORVS · CC0 1.0*